Results 21 to 30 of about 116,439 (236)
Early morphea simulating patch-stage mycosis fungoides in two cases
Dermatology Reports, 2018 Morphea is a skin disorder characterized by thickening of dermis and subcutaneous tissues and loss of adnexal structures. In the early inflammatory stage of morphea, diagnostic histological findings are absent and this may lead to confusion with other ...
Hamid R. Ghasemi Basir +3 more
doaj +1 more source
Frontiers in Medicine, 2023 BackgroundPsoriasis is a chronic skin disease affecting approximately 3.2% of the population. The 308 nm light emitting diode (LED) is a novel, portable, and cost-effective light source, may have potential in the treatment of localized psoriasis patients
Yingyuan Yu +7 more
doaj +1 more source
New England Journal of Medicine, 2005 Psoriasis is an immune-mediated, genetic disease manifesting in the skin or joints or both. A diverse team of clinicians with a range of expertise is often needed to treat the disease. Psoriasis provides many challenges including high prevalence, chronicity, disfiguration, disability, and associated comorbidity.
Boehncke, Wolf-Henning +1 more
openaire +8 more sources
Dysregulated Peripheral Invariant Natural Killer T Cells in Plaque Psoriasis Patients
Frontiers in Cell and Developmental Biology, 2022 Background: Psoriasis is a common immune-mediated skin disease that involves T-cell-mediated immunity. Invariant natural killer T (iNKT) cells are a unique lymphocyte subpopulation that share properties and express surface markers of both NK cells and T ...
Yifan Hu +25 more
doaj +1 more source
Frontiers in Immunology, 2023 BackgroundPsoriasis is a chronic inflammatory skin disease with effects that extend beyond the skin. Insulin resistance (IR) has been associated with psoriasis, but it remains unclear how indicators related to the triglyceride glucose (TyG) index, which ...
Dawei Huang +13 more
doaj +1 more source
Frontiers in Medicine, 2023 Ustekinumab is a biological therapy that has been approved for treating moderate-to-severe psoriasis. Although injection site reactions, nasopharyngitis, headaches, and infections are the common adverse events associated with ustekinumab, the development
Luyang Kong +13 more
doaj +1 more source
Frontiers in Medicine, 2023 BackgroundRandomized controlled trials indicated guselkumab, the first anti-interleukin-23 monoclonal antibody, is efficacious in plaque psoriasis. However, guselkumab's performance in real life is scarcely examined, especially in China.ObjectivesThis ...
Jianfeng Zheng +11 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Psoriasis is a chronic inflammatory disease characterized by erythematous scaly plaques, accompanied by systemic damage that leads to the development of multiple comorbidities.
Jiangluyi Cai +11 more
doaj +1 more source
High Healthcare Utilization Preceding Diagnosis with Juvenile Idiopathic Arthritis
Arthritis Care &Research, Accepted Article.Objective Though early diagnosis improves long‐term outcomes, Juvenile Idiopathic Arthritis (JIA) patients often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize healthcare utilization in the year preceding diagnosis.
Anna Costello +5 more
wiley +1 more source
Advanced Healthcare Materials, EarlyView.Comparison of therapeutic and diagnostic applications of a surface‐emitting light source with multiwavelength emission characteristics. Abstract Conventional light‐emitting‐diode‐based light sources suffer from rigidity, localized heating, and poor adaptability to skin deformation, limiting their use in skin‐attached medical devices.
In Ho Kim +10 more
wiley +1 more source